Bellevue Asset Management »

Bicara Therapeutics shares owned by Bellevue Asset Management

Quarter-by-quarter ownership of Bicara Therapeutics (BCAX) shares owned by Bellevue Asset Management from 13F filings

Historical chart of Bellevue Asset Management investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by Bellevue Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by Bellevue Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.0k 61 16.82

More positions owned by Bellevue Asset Management

First Tr Exchange-traded Risng Divd Achiv (RDVY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Capital Group Growth Etf Shs Creation Uni (CGGR)
First Tr Exchange- Traded Fst Low Oppt Etf (LMBS)
Amazon (AMZN)
Costco Wholesale Corporation (COST)
Jp Morgan Exchange Traded F Intrnl Res Eqt (JIRE)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Vanguard World Inf Tech Etf (VGT)
Tcw Etf Trust Flexible Income (FLXR)
Jp Morgan Exchange Traded F Short Dura Core (JSCP)
First Tr Exchange-traded First Tr Enh New (FTSM)
Starbucks Corporation (SBUX)
Jp Morgan Exchange Traded F Equity Premium (JEPI)

View all positions for Bellevue Asset Management

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Vestal Point Capital
T. Rowe Price Investment Management
Red Tree Management
Tpg Gp A
FMR
Deep Track Capital
BlackRock
Omega Fund Management
Vanguard Group
State Street Corporation
Franklin Resources
Blackstone Group
Millennium Management

View all funds holding Bicara Therapeutics